Cargando…

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?

Osteosarcoma and Ewing sarcoma are the most common malignant primary bone tumors mainly occurring in children, adolescents and young adults. Current standard therapy includes multidrug chemotherapy and/or radiation specifically for Ewing sarcoma, associated with tumor resection. However, patient sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danieau, Geoffroy, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck, Brounais-Le Royer, Bénédicte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696068/ https://www.ncbi.nlm.nih.gov/pubmed/31370265 http://dx.doi.org/10.3390/ijms20153751

Ejemplares similares

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?
por: Morice, Sarah, et al.
Publicado: (2020)

ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
por: Danieau, Geoffroy, et al.
Publicado: (2021)

Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
por: Morice, Sarah, et al.
Publicado: (2021)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
por: Lamora, Audrey, et al.
Publicado: (2016)

Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing’s Sarcoma Tumor Growth
por: Mullard, Mathilde, et al.
Publicado: (2020)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment
por: Brion, Régis, et al.
Publicado: (2022)

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
por: Morice, Sarah, et al.
Publicado: (2020)

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression
por: Lézot, Frédéric, et al.
Publicado: (2020)

Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors
por: Talbot, Julie, et al.
Publicado: (2020)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment
por: Verrecchia, Franck, et al.
Publicado: (2018)

Ewing sarcoma from molecular biology to the clinic
por: Dupuy, Maryne, et al.
Publicado: (2023)

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
por: Corre, Isabelle, et al.
Publicado: (2020)

Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells
por: Tesfaye, Robel A., et al.
Publicado: (2023)

The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway
por: Rodriguez Calleja, Lidia, et al.
Publicado: (2022)

Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
por: Muñoz-Garcia, Javier, et al.
Publicado: (2022)

LIM Kinases in Osteosarcoma Development
por: Brion, Régis, et al.
Publicado: (2021)

Molecular Alterations Associated with Osteosarcoma Development
por: Ando, Kosei, et al.
Publicado: (2012)

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases
por: Lamora, Audrey, et al.
Publicado: (2015)

The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
por: Wang, Kaiting, et al.
Publicado: (2022)

WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment
por: Li, Xin, et al.
Publicado: (2019)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015)

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
por: Jia, Lin, et al.
Publicado: (2019)

Wnt and β-Catenin Signaling in the Bone Metastasis of Prostate Cancer
por: Kaplan, Zachary, et al.
Publicado: (2021)

Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment
por: Ruan, Yongsheng, et al.
Publicado: (2020)

Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway
por: Hu, Kaimin, et al.
Publicado: (2015)

Insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and Porcupine
por: Cabrae, Régine, et al.
Publicado: (2020)

New Insights into Wnt–Lrp5/6–β-Catenin Signaling in Mechanotransduction
por: Kang, Kyung Shin, et al.
Publicado: (2015)

Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
por: Selvaggi, Federico, et al.
Publicado: (2022)

Physiopathological aspects of the Wnt/β-catenin signaling pathway in the male reproductive system
por: Lombardi, Ana Paola G., et al.
Publicado: (2013)

Activation of Wnt/Beta-Catenin Signaling Pathway as a Promising Therapeutic Candidate for Cerebral Ischemia/Reperfusion Injury
por: Mo, Zhizhun, et al.
Publicado: (2022)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis
por: Le Goff, Benoit, et al.
Publicado: (2009)

Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
por: Nguyen, Vu Hong Loan, et al.
Publicado: (2019)

Novel Insights into the Role of Kras in Myeloid Differentiation: Engaging with Wnt/β-Catenin Signaling
por: Yokoyama, Noriko, et al.
Publicado: (2023)

WNKs in Wnt/β-catenin signaling
por: Serysheva, Ekatherina, et al.
Publicado: (2014)

Wnt/β-Catenin Signaling and Obesity
por: Chen, Na, et al.
Publicado: (2018)

Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells
por: Chen, Changbao, et al.
Publicado: (2015)

A Review on the Crosstalk between Insulin and Wnt/β-Catenin Signalling for Bone Health
por: Wong, Sok Kuan, et al.
Publicado: (2023)

Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
por: Patel, Sonal, et al.
Publicado: (2019)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
por: Picarda, Gaëlle, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_318d89qj051980ki16hot48mpc